top of page


February 13, 2024

Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales

February 13, 2024

Ventripoint Announces Changes to
The Board of Directors

February 20, 2024

Ventripoint Successfully Showcases A.I.- Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences

January 24, 2024

Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint’s Clinical Advisory Board

January 3, 2024

Ventripoint Whitepaper Distribution.FINAL

December 12, 2023

ASCEND Cardiovascular to Market and Distribute Ventripoint’s AI-Powered Heart-Scanning Technology to North American  Hospitals and Clinics

December 5, 2023

 Ollie Hinkle Heart Foundation Will Introduce Ventripoint’s AI-Heart-Imaging Diagnostic Technology to America’s Hospitals

November 24, 2023

Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar  

November 9, 2023

Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference

November 3, 2023

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

November 1, 2023

Ventripoint to Hold Annual General Meeting of Shareholders on November 1, 2023

October 12, 2023

Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference

October 03, 2023

Ventripoint Announces Appointment of Chief Finance Officer

September 28, 2023

Ventripoint’s AI Heart Technology Takes Centre Stage In ITN Business “The Hidden Heart” Programme

September 15, 2023

Ventripoint to Sponsor DGPK Echo Advanced Workshop

September 13, 2023

Ventripoint to Sponsor 51st Annual Nordic Paediatric Cardiology Meeting

September 8, 2023

Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium

August 30, 2023

Ventripoint Diagnostics Reports Second Quarter 2023 Financial Results

Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar

August 25, 2023

August 22, 2023

Ventripoint Welcomes Evelina London Children’s Hospital as Newest VMS+ User

Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular

August 18, 2023

August 10, 2023

Ventripoint Announces Collaboration with Ascend Cardiovascular 

August 2, 2023

Ventripoint Diagnostics to Attend 8th World Congress of Paediatric Cardiology and Cardiac Surgery 

Ventripoint's VMS+ Purchased by University of Freiburg Medical Center

July 18, 2023

July 11, 2023

Ventripoint to Sponsor Advanced Imaging 2023 in London England

May 30, 2023

Ventripoint Receives European Union Medical Device Regulation Certification

July 5, 2023

Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany

May 29, 2023

Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results

May 17, 2023

Ventripoint Issues Option Grants and Reports Exercise of Options

May 2, 2023

Ventripoint Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

April 25, 2023

Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

March 16, 2023

Ventripoint Diagnostics Provides a Corporate Update

January 3, 2023

Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO

bottom of page